Cargando…
SAT-260 Resolution of a Cystic Macroprolactinoma with Dopamine Agonist Therapy
Background. Prolactinomas with cystic regions occupying ≥ 50% of tumor volume are classified as cystic prolactinomas. They appear to arise from tumor necrosis or hemorrhage. Though Pituitary Society guidelines recommend surgery as first-line treatment for cystic prolactinomas, there is evidence that...
Autores principales: | Ansari, Mohammad Jamal Uddin, Abdelkarim, Jumana, Baral, Shailesh, Parveen, Sanober, Mariam, Murtaza Ali, Jabri, Hadoun, Rehman, Anis, Jakoby, Michael G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209175/ http://dx.doi.org/10.1210/jendso/bvaa046.327 |
Ejemplares similares
-
SUN-404 Diabetes Insipidus and Hypopituitarism in a Patient with Transient Isolated Pituitary Stalk Enlargement
por: Parveen, Sanober, et al.
Publicado: (2019) -
SAT-673 Acute Onset Type 1 Diabetes Mellitus Caused by the Checkpoint Inhibitor Nivolumab
por: Ansari, Mohammad Jamal Uddin, et al.
Publicado: (2020) -
SAT-477 Pituitary Carcinoma Arising from a Macroprolactinoma
por: Gammoh, Emily, et al.
Publicado: (2019) -
SAT-258 Surprising Transformation of a Microprolactinoma to a Macroprolactinoma
por: Athonvarangkul, Diana, et al.
Publicado: (2020) -
SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)